Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 2—February 2018
Synopsis

Adenovirus Type 4 Respiratory Infections among Civilian Adults, Northeastern United States, 2011–20151

Adriana E. KajonComments to Author , Daryl M. Lamson, Camden R. Bair, Xiaoyan Lu, Marie L. Landry, Marilyn Menegus2, Dean D. Erdman, and Kirsten St. George
Author affiliations: Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA (A.E. Kajon, C.R. Bair); New York State Department of Health, Albany, New York, USA (D.M. Lamson, K. St. George); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (X. Lu, D.D. Erdman); Yale University School of Medicine, New Haven, Connecticut, USA (M.L. Landry); University of Rochester Medical Center, Rochester, New York, USA (M. Menegus)

Main Article

Figure 2

In silico restriction enzyme analysis of human adenovirus type 4 genomes representing the spectrum of genetic variability of the 36 isolates characterized in study of acute respiratory infection detected by New York State Department of Health surveillance, New York, USA, 2011–2015. We generated restriction enzyme profiles for the completely sequenced genomes obtained in this study and from reference sequences available in GenBank using Geneious Pro (31). 4p4 MIL is isolate NHR90339, 4a1 MIL is i

Figure 2. In silico restriction enzyme analysis of human adenovirus type 4 genomes representing the spectrum of genetic variability of the 36 isolates characterized in study of acute respiratory infection detected in the northeastern United States, 2011–2015. We generated restriction enzyme profiles for the completely sequenced genomes obtained in this study and from reference sequences available in GenBank using Geneious Pro (31). 4p4 MIL is isolate NHR90339, 4a1 MIL is isolate NHRC3, and 4a2 MIL is isolate 42606; 4a SmaI v is isolate NY11 (GenBank accession no. KY996449) and 4a SmaI/XhoI v is isolate NY24 (GenBank accession no. KY996446). MIL, military isolate; v, variant; Vac, vaccine strain.

Main Article

References
  1. Hilleman  MR, Werner  JH. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med. 1954;85:183–8. DOIPubMedGoogle Scholar
  2. Hilleman  MR, Werner  JH, Dascomb  HE, Butler  RL, Stewart  MT. Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. Am J Hyg. 1955;62:29–42.PubMedGoogle Scholar
  3. Van Der Veen  J, Van Der Ploeg  G. An outbreak of pharyngoconjunctival fever caused by types 3 and 4 adenovirus at Waalwijk, The Netherlands. Am J Hyg. 1958;68:95–105.PubMedGoogle Scholar
  4. Aoki  K, Kato  M, Ohtsuka  H, Ishii  K, Nakazono  N, Sawada  H. Clinical and aetiological study of adenoviral conjunctivitis, with special reference to adenovirus types 4 and 19 infections. Br J Ophthalmol. 1982;66:776–80. DOIPubMedGoogle Scholar
  5. Gomes  SA, Gabbay  YB, Nascimento  JP, Niel  C. Genome analysis of adenovirus 4a, a causative agent of pharyngoconjunctival fever and respiratory diseases in Brazil. J Med Virol. 1988;26:453–9. DOIPubMedGoogle Scholar
  6. Ariga  T, Shimada  Y, Ohgami  K, Tagawa  Y, Ishiko  H, Aoki  K, et al. New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in Japan. J Clin Microbiol. 2004;42:3644–8. DOIPubMedGoogle Scholar
  7. Hendrix  RM, Lindner  JL, Benton  FR, Monteith  SC, Tuchscherer  MA, Gray  GC, et al. Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in U.S. army trainees. Emerg Infect Dis. 1999;5:798–801. DOIPubMedGoogle Scholar
  8. Gray  GC, Goswami  PR, Malasig  MD, Hawksworth  AW, Trump  DH, Ryan  MA, et al.; Adenovirus Surveillance Group. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. Clin Infect Dis. 2000;31:663–70. DOIPubMedGoogle Scholar
  9. Kolavic-Gray  SA, Binn  LN, Sanchez  JL, Cersovsky  SB, Polyak  CS, Mitchell-Raymundo  F, et al. Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis. 2002;35:808–18. DOIPubMedGoogle Scholar
  10. Russell  KL, Hawksworth  AW, Ryan  MA, Strickler  J, Irvine  M, Hansen  CJ, et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine. 2006;24:2835–42. DOIPubMedGoogle Scholar
  11. Mölsä  M, Hemmilä  H, Rönkkö  E, Virkki  M, Nikkari  S, Ziegler  T. Molecular characterization of adenoviruses among finnish military conscripts. J Med Virol. 2016;88:571–7. DOIPubMedGoogle Scholar
  12. Broderick  MP, Hansen  CJ, Russell  KL. Exploration of the effectiveness of social distancing on respiratory pathogen transmission implicates environmental contributions. J Infect Dis. 2008;198:1420–6. DOIPubMedGoogle Scholar
  13. Russell  KL, Broderick  MP, Franklin  SE, Blyn  LB, Freed  NE, Moradi  E, et al. Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. J Infect Dis. 2006;194:877–85. DOIPubMedGoogle Scholar
  14. Adrian  T. Genome type analysis of adenovirus type 4. Intervirology. 1992;34:180–3. DOIPubMedGoogle Scholar
  15. Li  QG, Wadell  G. The degree of genetic variability among adenovirus type 4 strains isolated from man and chimpanzee. Arch Virol. 1988;101:65–77. DOIPubMedGoogle Scholar
  16. Kajon  AE, Moseley  JM, Metzgar  D, Huong  HS, Wadleigh  A, Ryan  MA, et al. Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003). J Infect Dis. 2007;196:67–75. DOIPubMedGoogle Scholar
  17. Houng  HS, Clavio  S, Graham  K, Kuschner  R, Sun  W, Russell  KL, et al. Emergence of a new human adenovirus type 4 (Ad4) genotype: identification of a novel inverted terminal repeated (ITR) sequence from majority of Ad4 isolates from US military recruits. J Clin Virol. 2006;35:381–7. DOIPubMedGoogle Scholar
  18. Dehghan  S, Seto  J, Liu  EB, Walsh  MP, Dyer  DW, Chodosh  J, et al. Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events. Virology. 2013;443:197–207. DOIPubMedGoogle Scholar
  19. Gutekunst  RR, White  RJ, Edmondson  WP, Chanock  RM. Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection. Am J Epidemiol. 1967;86:341–9. DOIPubMedGoogle Scholar
  20. van der Veen  J, Abarbanel  MF, Oei  KG. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy. J Hyg (Lond). 1968;66:499–511. DOIPubMedGoogle Scholar
  21. Hoke  CH Jr, Hawksworth  A, Snyder  CE Jr. Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012. MSMR. 2012;19:2–4.PubMedGoogle Scholar
  22. Radin  JM, Hawksworth  AW, Blair  PJ, Faix  DJ, Raman  R, Russell  KL, et al. Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis. 2014;59:962–8. DOIPubMedGoogle Scholar
  23. Brandt  CD, Kim  HW, Vargosko  AJ, Jeffries  BC, Arrobio  JO, Rindge  B, et al. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemiol. 1969;90:484–500. DOIPubMedGoogle Scholar
  24. Fox  JP, Brandt  CD, Wassermann  FE, Hall  CE, Spigland  I, Kogon  A, et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol. 1969;89:25–50. DOIPubMedGoogle Scholar
  25. Schmitz  H, Wigand  R, Heinrich  W. Worldwide epidemiology of human adenovirus infections. Am J Epidemiol. 1983;117:455–66. DOIPubMedGoogle Scholar
  26. Kajon  AE, Suarez  MV. Molecular epidemiology of adenoviruses isolated from hospitalized children with severe lower acute respiratory infection in Santiago, Chile. J Med Virol. 1990;30:294–7. DOIPubMedGoogle Scholar
  27. Kajon  AE, Mistchenko  AS, Videla  C, Hortal  M, Wadell  G, Avendaño  LF. Molecular epidemiology of adenovirus acute lower respiratory infections of children in the south cone of South America (1991-1994). J Med Virol. 1996;48:151–6. DOIPubMedGoogle Scholar
  28. Lu  X, Erdman  DD. Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene. Arch Virol. 2006;151:1587–602. DOIPubMedGoogle Scholar
  29. Lamson  DM, Kajon  A, Shudt  M, Girouard  G, St George  K. Detection and genetic characterization of adenovirus type 14 strain in students with influenza-like illness, New York, USA, 2014–2015. Emerg Infect Dis. 2017;23:1194–7. DOIPubMedGoogle Scholar
  30. Kajon  AE, Erdman  DD. Assessment of genetic variability among subspecies b1 human adenoviruses for molecular epidemiology studies. Methods Mol Med. 2007;131:335–55. DOIPubMedGoogle Scholar
  31. Kearse  M, Moir  R, Wilson  A, Stones-Havas  S, Cheung  M, Sturrock  S, et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012;28:1647–9. DOIPubMedGoogle Scholar
  32. Kimura  M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16:111–20. DOIPubMedGoogle Scholar
  33. Tamura  K, Stecher  G, Peterson  D, Filipski  A, Kumar  S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725–9. DOIPubMedGoogle Scholar
  34. Kandel  R, Srinivasan  A, D’Agata  EM, Lu  X, Erdman  D, Jhung  M. Outbreak of adenovirus type 4 infection in a long-term care facility for the elderly. Infect Control Hosp Epidemiol. 2010;31:755–7. DOIPubMedGoogle Scholar
  35. Lu  X, Trujillo-Lopez  E, Lott  L, Erdman  DD. Quantitative real-time PCR assay panel for detection and type-specific identification of epidemic respiratory human adenoviruses. J Clin Microbiol. 2013;51:1089–93. DOIPubMedGoogle Scholar
  36. Roy  S, Calcedo  R, Medina-Jaszek  A, Keough  M, Peng  H, Wilson  JM. Adenoviruses in lymphocytes of the human gastro-intestinal tract. PLoS One. 2011;6:e24859. DOIPubMedGoogle Scholar
  37. Stanley  ED, Jackson  GG. Spread of enteric live adenovirus type 4 vaccine in married couples. J Infect Dis. 1969;119:51–9. DOIPubMedGoogle Scholar
  38. Narra  R, Bono  P, Zoccoli  A, Orlandi  A, Piconi  S, Grasselli  G, et al. Acute respiratory distress syndrome in adenovirus type 4 pneumonia: A case report. J Clin Virol. 2016;81:78–81. DOIPubMedGoogle Scholar
  39. Kalimuddin  S, Chan  YFZ, Wu  IQ, Tan  QL, Murthee  KG, Tan  BH, et al. A report of adult human adenovirus infections in a tertiary hospital. Open Forum Infect Dis. 2017;4:ofx053. DOIPubMedGoogle Scholar
  40. Hang  J, Vento  TJ, Norby  EA, Jarman  RG, Keiser  PB, Kuschner  RA, et al. Adenovirus type 4 respiratory infections with a concurrent outbreak of coxsackievirus A21 among United States Army Basic Trainees, a retrospective viral etiology study using next-generation sequencing. J Med Virol. 2017;89:1387–94. DOIPubMedGoogle Scholar

Main Article

1Preliminary results from this study were presented at the 12th International Adenovirus Meeting, August 16–20, 2016; Barsinghausen, Germany.

2Deceased.

Page created: January 17, 2018
Page updated: January 17, 2018
Page reviewed: January 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external